Faculty, Staff and Student Publications
Publication Date
7-11-2024
Journal
Blood
DOI
10.1182/blood.2024024626
PMID
38990537
Keywords
Humans, Hypereosinophilic Syndrome, Janus Kinase 1, Janus Kinase 2, Leukemia, Mutation, Nitriles, Protein Kinase Inhibitors, Pyrazoles, Pyrimidines, Female, Aged
Published Open-Access
yes
Recommended Citation
Qing Wei and Jie Xu, "Chronic Eosinophilic Leukemia With a Novel JAK1 Mutation Responds Well to the JAK1/2 Inhibitor Ruxolitinib" (2024). Faculty, Staff and Student Publications. 5164.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5164
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Hematology Commons, Hemic and Lymphatic Diseases Commons, Medical Genetics Commons, Oncology Commons